SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : TGEN - Targeted Genetics Corporation -- Ignore unavailable to you. Want to Upgrade?

To: GlobalMarine who wrote (262)2/23/2000 6:23:00 PM
From: biowaRead Replies (1) | Respond to of 557
 
Rand,

Even a modest public offering of, say, $50 to $100 million may actually provide confidence that the company can follow through on its R & D

And perhaps bring some additional programs in/forward.

And perhaps weather whatever cold water Congress may try to throw on gene therapy.

biowa


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News